BHRT After Hysterectomy: What Changes and What Doesn’t

A hysterectomy is one of the most common major surgeries performed in Canada. Approximately 50,000 are performed annually, with the majority occurring in women between 40 and 55. The hormonal implications depend on exactly what was removed and how old the patient was at the time of surgery.

Many women leave the hospital with clear instructions about physical recovery and very little guidance about the hormonal consequences that may unfold over the following months and years.

Hysterectomy Types and Hormonal Impact

The hormonal picture after a hysterectomy depends on whether the ovaries were removed.

Total hysterectomy with bilateral salpingo-oophorectomy (removal of uterus, cervix, fallopian tubes, and both ovaries): This produces immediate surgical menopause. Estrogen, progesterone, and a significant portion of testosterone production cease abruptly. The hormonal transition is sudden and often severe.

Total hysterectomy with ovarian conservation (removal of uterus and cervix, ovaries left in place): Estrogen and testosterone production continue from the intact ovaries, but research shows that ovarian function may decline earlier than it would have naturally. A 2009 study in Obstetrics & Gynecology demonstrated that women who had a hysterectomy with ovarian conservation reached menopause an average of 1.9 years earlier than women who had not had surgery. Disruption of ovarian blood supply during the procedure is the likely mechanism.

Subtotal hysterectomy (removal of uterus body, cervix preserved): Similar to total hysterectomy regarding ovarian function, depending on whether ovaries were removed.

Surgical Menopause Is Different

Women who enter menopause surgically, through removal of both ovaries, experience a qualitatively different transition than women who reach menopause naturally.

Natural menopause is a gradual process. Ovarian function declines over years, with periods of fluctuation that allow the body to adapt incrementally. Surgical menopause is abrupt. Hormone levels that were present yesterday are gone today.

The symptom burden reflects this. Hot flashes, night sweats, sleep disruption, mood instability, cognitive changes, and vaginal dryness often arrive within days of surgery and with greater intensity than in natural menopause. Women who had no menopausal symptoms before surgery may find themselves profoundly symptomatic within the first week of recovery.

The psychological impact compounds the physical. A woman recovering from major surgery while simultaneously experiencing acute hormone withdrawal faces a dual challenge that is often underappreciated in post-surgical care.

Do You Still Need Progesterone Without a Uterus?

The conventional answer is no. The primary role of progesterone in traditional HRT is to protect the endometrium (uterine lining) from unopposed estrogen stimulation, which can increase the risk of endometrial hyperplasia and cancer. If there is no uterus, there is no endometrium to protect, and progesterone is deemed unnecessary.

This reasoning is narrowly correct and clinically incomplete.

Progesterone has significant extra-uterine effects. It supports sleep through its conversion to the neurosteroid allopregnanolone, which enhances GABA receptor activity. It modulates anxiety and mood. It contributes to bone formation through osteoblast stimulation. It has demonstrated neuroprotective properties in preclinical research.

A woman without a uterus who is experiencing insomnia, anxiety, or mood instability may benefit from micronized progesterone for its neurological and systemic effects, regardless of whether endometrial protection is needed.

The decision should be based on the patient’s symptom profile and clinical response, not solely on the presence or absence of a uterus. A physician who understands the breadth of progesterone’s physiological roles will assess each patient individually.

Estrogen After Hysterectomy

For women who have had their ovaries removed, estrogen replacement is not a luxury. Estrogen influences cardiovascular function, bone density, cognitive health, urogenital tissue integrity, body composition, and joint health. The abrupt loss of estrogen following bilateral oophorectomy accelerates risk across multiple systems, particularly by shifting body composition toward visceral adiposity and reducing metabolic capacity.

The 2017 Nurses’ Health Study analysis found that women who had bilateral oophorectomy before age 50 and did not take estrogen therapy had increased all-cause mortality compared to women who retained their ovaries or who took hormone therapy after oophorectomy. The loss of estrogen’s protective effects on body composition accelerates the shift toward visceral fat deposition and metabolic dysfunction that increases downstream disease risk.

Estrogen therapy after surgical menopause should be considered a medical intervention with clear benefits, initiated promptly when not contraindicated.

For women who have had a hysterectomy with ovarian conservation, estrogen replacement becomes relevant when ovarian function eventually declines. Regular monitoring of estradiol levels allows timely initiation of therapy when symptoms and blood work converge.

Testosterone After Hysterectomy

The ovaries contribute approximately 25 percent of a woman’s total testosterone production directly, with an additional 25 percent coming from ovarian precursors converted in peripheral tissues. Bilateral oophorectomy removes half of a woman’s testosterone supply in a single surgical event.

The remaining adrenal contribution is insufficient for many women to maintain adequate testosterone levels. Fatigue, loss of libido, reduced muscle mass, and diminished motivation following oophorectomy are often attributable to testosterone deficiency.

Even in women who retain their ovaries, hysterectomy can impair ovarian testosterone production through vascular disruption. Testosterone should be measured as part of the post-hysterectomy hormonal assessment and replaced when deficient.

Compounded transdermal testosterone at doses appropriate for women (typically 0.5 to 2 mg per day) can restore physiological levels and address the symptoms attributable to deficiency.

The Post-Hysterectomy Assessment

A thorough hormonal assessment after hysterectomy includes estradiol, progesterone, total and free testosterone, SHBG, DHEA-S, a complete thyroid panel, fasting insulin, and metabolic markers. The specific panel depends on whether ovaries were retained and how much time has elapsed since surgery.

Symptoms are mapped across the Sensus domain: sleep quality, mood, anxiety, libido, energy, cognitive clarity, and vasomotor symptoms. Blood work populates the Pulsus domain. Physical function, body composition, and exercise capacity are captured in the Virtus domain.

The treatment protocol is built from this complete picture, not from the surgical history alone.

Timing Matters

For women who undergo bilateral oophorectomy, hormone therapy should be discussed before surgery, not months after when symptoms have already become severe. Ideally, hormone replacement begins within days to weeks of surgery, allowing the transition to occur with support rather than in withdrawal.

For women whose ovaries were conserved, annual monitoring of hormonal levels helps detect the earlier-than-expected decline that hysterectomy can accelerate. Proactive assessment prevents the common scenario where a woman suffers for years before the hormonal contribution is recognized.

The surgery has already happened. What happens next is a choice.

Continue Reading

If you found this useful, these related articles may deepen your understanding:

• BHRT vs. Conventional HRT
• Progesterone: The Most Underrated Hormone in Women’s Health
• Hormone Therapy and Breast Cancer Risk

---

Dr. Handsun Xiao is a McGill trained physician (MD, CCFP) practicing functional medicine and bioidentical hormone therapy in Toronto, with virtual consultations available to patients across Ontario. He holds advanced BHRT certification through WorldLink Medical and IFM AFMCP training. Manus Solis offers physician led BHRT consultations with custom compounding through a dedicated Ontario pharmacy partner. To learn more or book a virtual consultation, visit manussolis.ca.